Sarah Teichmann given Helmholtz International Fellow Award

Head of Cellular Genetics recognised with 20,000 Euros to further her research and an invitation to a research stay at Helmholtz Zentrum München (the German Research Centre for Environmental Health).

Sarah Teichmann given Helmholtz International Fellow Award

Dr Sarah Teichmann, Head of Cellular Genetics at the Wellcome Sanger InstituteWellcome Sanger Institute
Dr Sarah Teichmann, Head of Cellular Genetics at the Wellcome Sanger Institute

Dr Sarah Teichmann is one of five scientists to receive this year's Helmholtz International Fellow Award, and the only researcher from the medical sector to be honoured. The awards ceremony is scheduled for the 5 May 2017 at the Helmholtz Campus in Neuherberg near Munich.

Professor Dr. Dr. Fabian Theis, who is collaborating with Dr Teichmann to develop the ‘Human Cell Atlas’ project, nominated Sarah for the award.

“I cannot imagine a better award winner. She is highly qualified and her research is very close to the topics our centre is focused on. This makes her the perfect candidate for this award.”

Professor Dr. Dr. Fabian Theis, Director of the Institute of Computational Biology (ICB) at the Helmholtz Zentrum München

Born in Karlsruhehe, the 41-year-old researcher first made her name in the field of the structure analysis of proteins. During her doctoral studies at the University of Cambridge, Sarah was involved in 15 published studies. In the mid-1990s she extended her expertise to analysing DNA and whole genomes. This was particularly exciting research period as it was during this time that the first genomes were mapped.

Further work led her to the newly emerging research field of network biology and she moved to the EMBL-European Bioinformatics Institute and the Wellcome Trust Sanger Institute in 2013 to pursue her research. Now the Head of the Cellular Genetics programme at the Sanger Institute, Sarah is primarily focused on utilising data from single cells (genome, epigenome, transcriptome) to understand the global regulation of gene expression and map the development of individual cells and cell types.

Sarah's research speaks for itself with more than 120 publications and 16,000 citations. She has led studies published in high-impact journals such as Science and Cell and is a Fellow of the Academy of Medical Sciences. She has been awarded a wide range of grants, including an ERC Consolidator Grant on the topic of single cell analyses, reflecting the respect that her research garners.

Notes to Editors
Further information

The Helmholtz International Fellow Award was first awarded in 2012. Since then, the award has been presented each year to 10 scientists in total in two selection rounds. So far, a total of 63 people have received the award. The prize is financed from the Helmholtz president's Initiative and Networking Fund. The Helmholtz centers nominate the candidates, and the Helmholtz President’s Council selects the award winners. Applications for the next selection round must be filed by 11 May 2017. The selection will be made at the President’s Council meeting to be held at the end of June 2017.

Selected Websites
Contact the Press Office

Dr Samantha Wynne, Media Officer

Tel +44 (0)1223 492 368

Emily Mobley, Media Officer

Tel +44 (0)1223 496 851

Wellcome Sanger Institute,
CB10 1SA,

Mobile +44 (0) 7900 607793

Recent News

Emma Davenport and Hilary Martin to lead research groups in the Human Genetics Programme

The faculty appointments, starting in Autumn 2018, will help the Sanger Institute establish foundational knowledge of how variation in DNA contributes to health and disease

New Sanger Institute Human Cell Atlas projects funded by the Chan Zuckerberg Initiative DAF, an advised fund of Silicon Valley Community Foundation

Projects will build computational tools to support the global Human Cell Atlas initiative to map every cell type in the body

Advance access to data: Researchers post genetic profiles of human and mouse cells on Human Cell Atlas online portal before publication

Prior to publishing their results, researchers compile and make raw data openly accessible on the preview version of the HCA Data Coordination Platform